Analysis of Risk Factors of Coagulation Dysfunction and Hemorrhage in Newly Diagnosed Hyperleukocytic Acute Myeloma Leukemia

Table 3

Survival Cox analysis of regression.

	Wald	B	Exp (B)	S.E.	Sig.
DD	5.019	0.01	1.211	0.005	0.024
WBC >200 × 10^9//L	7.089	0.004	1.104	0.829	0.008
Age	9.474	0.029	1.03	0.009	0.2
Heart failure	11.827	1.661	1.190	0.483	0.190
PLT (×10^9//L)	5.102	0.01	0.932	0.005	0.581
PT	4.333	0.018	1.018	0.009	0.084
APTT	7.921	0.024	1.029	0.033	0.396
TT	13.751	0.236	1.022	0.002	0.627
FIB	9.231	0.012	1.012	0.079	0.094
CKMB	7.510	0.031	1.043	0.091	0.434
CD13+	8.232	0.038	0.945	0.341	0.934
CD117+	7.27	0.918	1.011	0.641	0.132
CD33+	6.69	0.024	1.036	0.669	0.413
Abnormal coagulation function indicators	6.969	0.401	1.494	0.152	0.08
WT1+	1.788	0.472	1.604	0.480	0.618
FLT3+	9.763	0.145	1.081	0.065	0.963
Apheresis	9.14	1.031	1.201	0.259	0.339
Hydroxycarbamide	8.64	0.017	1.086	0.031	0.079

; .